Invention Grant
- Patent Title: Extracellular DNA as a therapeutic target in neurodegeneration
-
Application No.: US15576611Application Date: 2016-05-11
-
Publication No.: US11701410B2Publication Date: 2023-07-18
- Inventor: Dmitry Dmitrievich Genkin , Georgy Viktorovich Tets , Viktor Veniaminovich Tets
- Applicant: CLS THERAPEUTICS LIMITED
- Applicant Address: GG Saint Peter Port
- Assignee: CLS THERAPEUTICS LIMITED
- Current Assignee: CLS THERAPEUTICS LIMITED
- Current Assignee Address: GG Saint Peter Port
- Agency: Entralta PLLC
- Agent James F. Fleming; Peter D. Weinstein
- International Application: PCT/RU2016/000284 2016.05.11
- International Announcement: WO2016/190780A 2016.12.01
- Date entered country: 2017-11-22
- Main IPC: A61K38/46
- IPC: A61K38/46 ; A61K47/61 ; A61K9/00 ; A61P25/28 ; A61P25/18 ; A61P25/16
Abstract:
The invention relates to the use of deoxyribonuclease (DNase) enzyme for inhibiting progression and for prevention and treatment of neurodegeneration.
Public/Granted literature
- US20180360925A1 EXTRACELLULAR DNA AS A THERAPEUTIC TARGET IN NEURODEGENERATION Public/Granted day:2018-12-20
Information query
IPC分类:
